This is a joint podcast between The Lancet Rheumatology and The Lancet Regional Health - Western Pacific with Prof Xue Li. Biologics have become a mainstay of treatment in Rheumatology in Western populations, but in many parts of Asia, especially lower-and-middle-income countries, there remains substantial inequity in access due to differences in availability and affordability.

In this episode, we explore the factors that may have delayed the popularisation of biologics in Asia, any recent policy changes and the role of biosimilars in this landscape.

Read the full article:

https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(22)00121-3/fulltext?dgcid=buzzsprout_icw_podcast_June_25_lanwpc

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Prof. Allison Aiello joins Editor-in-chief Taissa Vila to talk about early predictors of Alzheimer’s disease. Prof. Aiello’s recent study reveals that key risk factors are associated with cognitive decline as early as ages 24 to 44, challenging the traditional focus on older populations. Tune in to learn how these early indicators could transform Alzheimer’s research and shift the narrative around Alzheimer’s prevention.

Prof. Aiello is James S. Jackson Healthy Longevity Professor of Epidemiology in the Robert N. Butler Columbia Aging Center and in this episode we explored a fresh perspective on the disease’s pathogenesis and the future of early intervention.

Read the full article:

https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00097-3/fulltext?dgcid=buzzsprout_icw_podcast_May_25_laname

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Non-communicable diseases (NCDs) such as cardiovascular disease, cancer, diabetes, and chronic respiratory conditions are the leading cause of premature mortality in Europe, yet efforts to prevent and control NCDs are inadequate.

Gauden Galea (WHO Regional Office for Europe, Copenhagen, Denmark) and David Stuckler (University of Bocconi, Milan, Italy) talk with Heather Brown (The Lancet Regional Health Europe) about their Health Policy paper introducing quick buys: 25 evidence-based cost-effective interventions that can have measurable public health benefits within 5 years.

The quick buys provide policymakers with practical ways in which they can accelerate progress towards global health targets and save lives.

Read the full article:

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00073-0/fulltext?dgcid=buzzsprout_icw_podcast_01-05-25_lanepe

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv